Delivery Order SPE2DB24D2003-SPE2DB25FXLB2
- Not listed
- The Defense Logistics Agency awarded a $35,358.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections. The contract, designated as a non-set-aside competitive award, calls for completion by August 18, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,266.90 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. The contract, which is not set-aside and was competitively awarded, has a performance location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order operates under a firm fixed price structure and represents a child contract issued against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,525.20. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,143.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 18, 2025. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a delivery order contract valued at $3,813.85 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This competitive, firm fixed-price delivery order is set to be completed by July 28, 2025, with performance occurring at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order issued under a larger contract vehicle supporting the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections with a ceiling value of $5,860.42. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $16,297.57 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a $13,067.60 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens under a firm fixed price contract. The order is scheduled for completion by August 8, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a relatively small-value transaction...
- The Defense Logistics Agency awarded a $19,343.26 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and requires completion by July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,724.55 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLB2Delivery Order
The Defense Logistics Agency awarded a $13,457.64 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 28, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement. The company's comprehensive pharmaceutical portfolio supports the Defense Health Agency and other government healthcare systems through its prime vendor agreement, which covers a broad range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic areas. This particular delivery order for Zepbound reflects the contractor's role in supplying specialty pharmaceutical products to support Department of Defense medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 7/25/25 |